Specialty code 174400000X · Orange, CA
NPI
1487716544
Since 2006
Specialty
Specialty code 174400000X
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1140 W la Veta Ave Ste 420
Orange, CA, 92868
Phone (714) 285-1904
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
2,400 services
Medicare patients, 2024
185
Average age 78
Drug cost, 2024
$4.5M
4,857 prescriptions
Company payments, 2025
$551
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel O Mayeda was code 99458 (e&m - miscellaneous), 722 times for 38 patients. In total Samuel O Mayeda billed 2,400 services in 21 codes, and Medicare paid $115K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99458 E&M - Miscellaneous | Office | 722 | 38 | $32.26 | $23K |
| 99214 Office E&M - Established | Office | 501 | 162 | $94.69 | $47K |
| 99457 E&M - Miscellaneous | Office | 352 | 38 | $40.47 | $14K |
| 36415 Venipuncture Blood Collection | Office | 308 | 105 | $8.65 | $2,664 |
| 99454 E&M - Miscellaneous | Office | 286 | 36 | $41.65 | $12K |
| 99215 Office E&M - Established | Office | 45 | 42 | $132.87 | $5,979 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 29 | 21 | $23.44 | $680 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 20 | 16 | $45.34 | $907 |
| 90662 Vaccine Product | Office | 13 | 13 | $81.82 | $1,064 |
| G0008 Administration of influenza virus vaccine | Office | 13 | 13 | $35.02 | $455 |
| 93000 Electrocardiogram | Office | 12 | 11 | $12.10 | $145 |
| 99213 Office E&M - Established | Office | 12 | 12 | $73.23 | $879 |
| 99205 Office E&M - New | Office | 11 | 11 | $151.78 | $1,670 |
By year: 2022 $71K for 1,009 services; 2023 $101K for 1,774 services; 2024 $115K for 2,400 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 308 | 105 | $8.65 | $2,664 |
Medicare prescription drug claims, 2024
In 2024, the drug Samuel O Mayeda prescribed most often to Medicare patients was Levothyroxine Sodium, with 323 prescriptions and refills. In total Samuel O Mayeda wrote 4,857 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 323 | 928 | 79 | $4,170 |
| Ezetimibe Generic | 234 | 647 | 66 | $8,351 |
| Rosuvastatin Calcium Generic | 183 | 532 | 60 | $2,956 |
| Amlodipine Besylate Generic | 162 | 485 | 53 | $1,865 |
| Telmisartan Generic | 128 | 355 | 36 | $5,625 |
| Metformin Hcl Generic | 125 | 350 | 32 | $1,216 |
| Ozempic Semaglutide | 125 | 169 | 23 | $147K |
| Atorvastatin Calcium Generic | 125 | 351 | 39 | $1,267 |
| Synthroid Levothyroxine Sodium | 124 | 339 | 32 | $13K |
| Mounjaro Tirzepatide | 87 | 133 | 16 | $137K |
| Glimepiride Generic | 82 | 246 | 27 | $962 |
| Pantoprazole Sodium Generic | 81 | 209 | 21 | $1,362 |
| Losartan Potassium Generic | 72 | 198 | 22 | $659 |
| Allopurinol Generic | 71 | 211 | 21 | $792 |
| Jardiance Empagliflozin | 57 | 128 | 19 | $73K |
Brand drugs: 1,258 claims; generic drugs: 3,491 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samuel O Mayeda $551 ($551 in general payments such as food, travel and fees) from 18 companies. The largest payer was Novartis Pharmaceuticals Corporation with $80.86.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 3 | $80.86 |
| Insulet Corporation PODD | 1 | $43.74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40.49 |
| Amgen Inc. AMGN | 2 | $34.18 |
| IBSA Pharma Inc. | 2 | $33.57 |
| Sandoz Inc. SDZ.SW | 1 | $32.07 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $31.61 |
| Exact Sciences Corporation EXAS | 1 | $31.1 |
| Abbvie Inc. ABBV | 1 | $29.81 |
| Recordati_rare_diseases_inc. | 1 | $27.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.